In contrast, EBV+ large B-cell lymphoma (LBCL) in young patients (age < 45 years) shows frequent (77%) PD-L1 overexpression on tumor cells, preferential nodal involvement, and an excellent prognosis [118]. This evidence concerns the gene CD274 and neoplasm.